Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced today that the U.S. Food and Drug Administration (FDA) designated Otulfi® (ustekinumab-aauz) as an interchangeable ...

Doctors often use biologic drugs on people with moderate to severe psoriasis. Moderate psoriasis ... A history of infections such as tuberculosis A history of cancer A weak immune system because ...

"We are so honored to partner with Art Garfunkel to share his ILUMYA story and to bring greater awareness to the impact psoriasis has beyond the physical symptoms," said Maureen Shannon, Head of ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

By embracing psoriasis biosimilars ... There were no cases of tuberculosis reactivation. The review authors noted organizations like the Biologics and Biosimilars Collective Intelligence Consortium ...

You’ll need to have some medical tests before your dermatologist can tell whether a biologic can be prescribed to treat your psoriasis. Blood tests and tuberculosis (TB) testing are typically required ...

Biologic therapy was considered ... effective short-term treatment for psoriasis, particularly for patients with comorbidities such as obesity or latent tuberculosis. Common adverse effects ...

3,6,8,9 While there is no cure for psoriasis, biologic therapies have transformed treatment ... Long-term use requires monitoring for infections, especially tuberculosis, and potential ...